Patients with relapsed or refractory diffuse large B-cell lymphoma have a poor prognosis. Glofitamab, a novel T-cell–engaging bispecific antibody, might improve outcomes in these patients. New research findings are summarized in a short video. https://nej.md/3UGxXF7 | The New England Journal of Medicine
2:04
FacebookThe New England Journal of Medicine
Patients with relapsed or refractory diffuse large B-cell lymphoma have a poor prognosis. Glofitamab, a novel T-cell–engaging bispecific antibody, might improve outcomes in
The New England Journal of Medicine. . Patients with relapsed or refractory diffuse large B-cell lymphoma have a poor prognosis. Glofitamab, a novel T-cell–engaging bispecific antibody, might improve outcomes in these patients. New research findings are summarized in a short video. https://nej.md/3UGxXF7
2.1K viewsDec 14, 2022
Related Products
B-cell Profile Glofitamab
Crystal Structure Glofitamab
Lunsumio Glofitamab
#Glofitamab Clinical Trials
Where to Get Paid for Clinical Trials in Australia - Stay at Home Mum
Where to Get Paid for Clinical Trials in Australia - Stay at Home Mum
stayathomemum.com.au7 months ago
Clinical Research & Trials
Clinical Research & Trials
edwards.comDec 4, 2022
Top videos
Roche presents new data demonstrating the potential benefit of glofitamab and Lunsumio as fixed-duration, off-the-shelf treatment options for lymphoma
Roche presents new data demonstrating the potential benefit of glofitamab and Lunsumio as fixed-duration, off-the-shelf treatment options for lymphoma
marketscreener.com
Dec 12, 2022
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma
3:02
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma
YouTubeGlobal Resource for
551 viewsMay 3, 2024
COLUMVI (glofitamab-gxbm)- relapsed or refractory diffuse large B-cell lymphoma
1:57
COLUMVI (glofitamab-gxbm)- relapsed or refractory diffuse large B-cell lymphoma
YouTubePharmacy Talk USA
438 viewsAug 11, 2024
Glofitamab Mechanism of Action
Pharmacology - Antiemetics
15:53
Pharmacology - Antiemetics
YouTubeArmando Hasudungan
678.6K viewsAug 13, 2017
Pharmacology - NSAIDs & PROSTAGLANDIN ANALOGS (MADE EASY)
11:01
Pharmacology - NSAIDs & PROSTAGLANDIN ANALOGS (MADE EASY)
YouTubeSpeed Pharmacology
1.3M viewsDec 7, 2017
Pharmacology - BENZODIAZEPINES, BARBITURATES, HYPNOTICS (MADE EASY)
8:21
Pharmacology - BENZODIAZEPINES, BARBITURATES, HYPNOTICS (MADE EASY)
YouTubeSpeed Pharmacology
1.1M viewsSep 17, 2018
Roche presents new data demonstrating the potential benefit of glofitamab and Lunsumio as fixed-duration, off-the-shelf treatment options for lymphoma
Roche presents new data demonstrating the potential benefi…
Dec 12, 2022
marketscreener.com
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cell Lymphoma
3:02
Efficacy of Epcoritamab and Glofitamab in Diffuse Large B-Cel…
551 viewsMay 3, 2024
YouTubeGlobal Resource for Advancing Cancer Education
COLUMVI (glofitamab-gxbm)- relapsed or refractory diffuse large B-cell lymphoma
1:57
COLUMVI (glofitamab-gxbm)- relapsed or refractory diffuse larg…
438 viewsAug 11, 2024
YouTubePharmacy Talk USA
Glofit-GemOx shows clinically meaningful benefit in relapsed/refractory diffuse large B-cell lym...
5:07
Glofit-GemOx shows clinically meaningful benefit in relapsed/refr…
145 viewsSep 20, 2024
YouTubeecancer
Linfoma diffuso a grandi cellule B ricaduto/refrattario, via libera Aifa al bispecifico glofitamab
7:21
Linfoma diffuso a grandi cellule B ricaduto/refrattario, via libera Aifa …
651 viewsApr 16, 2024
YouTubePharmaStarTV
Glofitamab & Pirtobrutinib for Relapsed/Refractory Mantle Cell Lymphoma -Blood Cancers Video Library
3:52
Glofitamab & Pirtobrutinib for Relapsed/Refractory Mantle Cell L…
100 viewsMay 25, 2023
YouTubeGlobal Resource for Advancing Cancer Education
Dr Abramson on Findings with Glofitamab, Gemcitabine and Oxaliplatin in R/R DLBCL | OncLive
Dr Abramson on Findings with Glofitamab, Gemcitabine and Oxal…
11 months ago
onclive.com
2:21
Important practical considerations for the use of glofitamab for DLBCL
198 viewsNov 1, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
4:22
Treatment Options of B-Cell Lymphoma: Glofitamab vs. Epcori…
843 viewsJul 31, 2024
YouTubeGlobal Resource for Advancing Cancer Education
1:06
Relapsed DLBCL after multiple lines of therapy… what options remain?
5 views2 months ago
YouTube5MinuteHematology
22:19
Challenging Cases with Relapsed/Refractory Diffuse Larg…
3.2K views10 months ago
YouTubeOncBrothers: Practice-Changing Cancer Discus…
7:13
Efficacy and safety of glofitamab for patients with Richter’s transforma…
283 viewsJul 28, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:08
The CRS-RS.5p predictive model of CRS after glofitamab treatment in …
24 views4 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:15
The benefits of glofitamab in R/R DLBCL post-CAR-T therapy
938 viewsJul 28, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:33
Glofitamab as a single agent in heavily pretreated patients with D…
328 viewsJul 26, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
1:24
The efficacy of glofitamab in patients with heavily pre-treated R…
235 views7 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
0:15
用于弥漫大B细胞淋巴瘤！「格菲妥单抗」新适应症在华获批
256 viewsMay 8, 2025
bilibili北京医伴旅
6:24
ICML 2025 | Initial results from LOTIS-7 for loncastuximab tesirin…
207 views11 months ago
YouTubeLymphoma Hub
2:00
ICML 2025 | Initial results from LOTIS-7 for loncastuximab tesirin…
516 views10 months ago
YouTubeLymphoma Hub
1:29
STARGLO 2-year follow-up: durability of responses in patient…
214 views11 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:30
Glofitamab in R/R DLBCL: updated safety and efficacy data
592 viewsOct 21, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:44
Glofitamab and obinutuzumab in r/r MCL
451 viewsDec 11, 2021
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:11
Glofitamab and obinutuzumab as first-line therapy for patients with …
144 views5 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
2:06
Linfoma diffuso a grandi cellule B, via libera Aifa a un nuovo farmaco
669 viewsApr 11, 2024
DailymotionAgenzia di Stampa ITALPRESS
8:12
Drs. Melody, Phillips discuss glofitamab trial, other MCL highlig…
238 views8 months ago
YouTubeThe Society of Hematologic Oncology
1:07
ASH 24: Dr. Breno Gusmão - Linfoma Difuso de Grandes Célula…
186 viewsDec 12, 2024
YouTubeABRALE - Associação Brasileira de Câncer do …
1:31
Advantages of bispecific antibodies for lymphoma: mosunetuzumab, e…
910 viewsJun 27, 2023
YouTubeVJHemOnc – Video Journal of Hematology & H…
5:46
Glofitamab and polatuzumab vedotin in DLBCL
811 viewsFeb 2, 2022
YouTubeVJHemOnc – Video Journal of Hematology & H…
3:16
Results from the LOTIS-7 trial: loncastuximab tesirine plus glofita…
188 views10 months ago
YouTubeVJHemOnc – Video Journal of Hematology & H…
See more videos
Static thumbnail place holder